Categories: News

MyMedBot launches COVID-19 vaccine management solution for businesses and schools

MyMedBot, a digital health start-up helping organizations reopen safely during the Coronavirus pandemic, has announced that it will integrate a COVID-19 vaccination management system into its health screening solution

LUXEMBOURG, Dec. 11, 2020 /PRNewswire/ — MyMedBot’s mobile application and web dashboard will enable organizations to easily log the vaccination status of their community members. It is customizable to fully support different types of vaccines and regulatory requirements. The current MyMedBot platform has already been used to conduct more than 2.5 million health screenings for over 180 organizations across the USA and Canada.

The announcement comes just as the Pfizer-BioNTech vaccine received a “green light” from the FDA advisory panel, creating hope that the world may begin to reopen safely from this pandemic. Yet, it is not clear how the vaccine will be distributed and how individual immunization status will be verified. Business leaders will need tools and solutions to identify those who have been vaccinated to maintain safe working conditions and prevent further shutdowns. No such solutions are yet available on the market.

With the MyMedBot health screening solution, organizations will be able to decide what information is to be provided by their community members and what vaccination verification proof is required. MyMedBot’s online dashboard will configure the immunization protocol and its mobile application will feed immunization data to the dashboard.

Commenting, MyMedBot CEO and Founder, Jacob Arnould, said: “MyMedBot’s vision has been from day one to provide peace-of-mind to its communities, with applications that can be rapidly deployed – no tech knowledge necessary. The new developments fulfill this vision. Easy to use and effective.

Every day, MyMedBot provides peace of mind for over 80,000 people to enter their classrooms or offices safely. The solution is easy to implement and affordable for all types of organizations, large and small.

About MyMedBot

MyMedBot is a digital health start-up based in Luxembourg, which provides health screening software for schools and businesses across the US, Canada, Europe and the Middle East. The company has already conducted more than 2.5 million daily health screenings via its mobile application and web dashboard.

mymedbot.lu

Note for press

Contact:
Jacob Arnould
press@mymedbot.lu
+1 (929) 955-1176

View original content:http://www.prnewswire.com/news-releases/mymedbot-launches-covid-19-vaccine-management-solution-for-businesses-and-schools-301191137.html

SOURCE MyMedBot

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

10 hours ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

13 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

13 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

13 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

13 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

13 hours ago